Cytomegaloviral Retinitis-related Retinal Detachment: Outcomes Following Vitrectomy in the Developing World

Overview

Journal Int Ophthalmol

Specialty Ophthalmology

Date 2013 Jun 21

PMID 23783657

Citations 6

Authors

Sri K Gore

Daniel M Gore

Kreasen Chetty

Linda Visser

Affiliations

Soon will be listed here.

Abstract

The purpose of this study is to describe the functional and anatomical outcomes of cytomegaloviral retinitis (CMVR) patients undergoing vitrectomy for retinal detachment (RD) in South Africa. In this retrospective case series, CMVR diagnoses were based on clinical examination alone. All vitrectomies were performed by a single surgeon. Main outcome measures were visual acuity (VA) and retinal re-attachment success rate. Thirty-nine patients (43 eyes) were followed up from the time of RD diagnosis for a mean 19.3 months ± 13.8 (standard deviation). Successful anatomical re-attachment was achieved in 38 (88 %) eyes. Silicone oil was used as initial tamponade in 39 eyes, with C3F8 being used in the remaining four (9 %) eyes with ≤2 small retinal breaks. The presence of high-grade proliferative vitreoretinopathy (n = 11 eyes, 26 %) was not associated with a greater risk of re-detachment (p = 0.24, Fisher's exact test). Functional outcomes were limited, with an overall rate of legal blindness (≤6/60) from the time of RD diagnosis of 0.58/eye year. Final VA strongly correlated with VA at the time of RD diagnosis (p = 0.018, paired t test). Two eyes (5 %) lost perception of light during the study period. Severe visual impairment is likely following CMVR-related RD in a developing world healthcare setting, despite successful anatomical re-attachment in most cases.

Citing Articles

Retinal detachment and mortality in patients with cytomegalovirus retinitis: A multicenter study in taiwan.

Wu P, Kang E, Chen W, Garg S, Chiang W, Lee M Graefes Arch Clin Exp Ophthalmol. 2024; 263(2):393-403.

PMID: 39422751 DOI: 10.1007/s00417-024-06651-2.

Long-term Outcomes of Surgeries for Retinal Detachment Secondary to Parasitic or Viral Infectious Retinitis.

Jung H, Lee J, Lee C, Kim M, Kim S, Byeon S Korean J Ophthalmol. 2024; 38(3):236-248.

PMID: 38712388 PMC: 11175980. DOI: 10.3341/kjo.2024.0010.

Comparison of two different intravitreal treatment regimens combined with systemic antiviral therapy for cytomegalovirus retinitis in patients with AIDS.

Liang X, An H, He H, Shen B, Ou Z, Li L AIDS Res Ther. 2023; 20(1):46.

PMID: 37452370 PMC: 10347846. DOI: 10.1186/s12981-023-00543-x.

Outcomes of 25-gauge pars plana vitrectomy for cytomegalovirus retinitis-related retinal detachment.

Moharana B, Dogra M, Tigari B, Singh S, Katoch D, Arora A Indian J Ophthalmol. 2021; 69(9):2361-2366.

PMID: 34427223 PMC: 8544073. DOI: 10.4103/ijo.IJO_3539_20.

Visual prognosis, clinical features, and predisposing factors in non-HIV patients with cytomegalovirus retinitis.

Shoeibi N, Abrishami M, Mohammad Esmaeil E, Hosseini S Int Ophthalmol. 2018; 39(8):1709-1715.

PMID: 30030661 DOI: 10.1007/s10792-018-0991-2.

References

Schulze-Bonsel K, Feltgen N, Burau H, Hansen L, Bach M . Visual acuities "hand motion" and "counting fingers" can be quantified with the freiburg visual acuity test. Invest Ophthalmol Vis Sci. 2006; 47(3):1236-40. DOI: 10.1167/iovs.05-0981. View

Brar M, Kozak I, Freeman W, Oster S, Mojana F, Yuson R . Vitreoretinal interface abnormalities in healed cytomegalovirus retinitis. Retina. 2010; 30(8):1262-6. DOI: 10.1097/IAE.0b013e3181cea6c1. View

Jabs D, Enger C, Haller J, De Bustros S . Retinal detachments in patients with cytomegalovirus retinitis. Arch Ophthalmol. 1991; 109(6):794-9. DOI: 10.1001/archopht.1991.01080060058024. View

Goldberg D, Wang H, Azen S, Freeman W . Long term visual outcome of patients with cytomegalovirus retinitis treated with highly active antiretroviral therapy. Br J Ophthalmol. 2003; 87(7):853-5. PMC: 1771778. DOI: 10.1136/bjo.87.7.853. View

Garcia R, Quiceno J, Capparelli E, Munguia D, Kuppermann B, Arevalo F . Results of rhegmatogenous retinal detachment repair in cytomegalovirus retinitis with and without scleral buckling. Ophthalmology. 1995; 102(2):236-45. DOI: 10.1016/s0161-6420(95)31030-5. View

Lim J, Enger C, Haller J, Campochiaro P, Meredith T, De Bustros S . Improved visual results after surgical repair of cytomegalovirus-related retinal detachments. Ophthalmology. 1994; 101(2):264-9. DOI: 10.1016/s0161-6420(13)31339-6. View

Jabs D . Cytomegalovirus retinitis and the acquired immunodeficiency syndrome--bench to bedside: LXVII Edward Jackson Memorial Lecture. Am J Ophthalmol. 2010; 151(2):198-216.e1. PMC: 3057105. DOI: 10.1016/j.ajo.2010.10.018. View

Thorne J, Jabs D, Kempen J, Holbrook J, Nichols C, Meinert C . Causes of visual acuity loss among patients with AIDS and cytomegalovirus retinitis in the era of highly active antiretroviral therapy. Ophthalmology. 2006; 113(8):1441-5. DOI: 10.1016/j.ophtha.2006.03.022. View

Visser L . Managing CMV retinitis in the developing world. Community Eye Health. 2007; 16(47):38-9. PMC: 1705847. View

10.

Jabs D, Van Natta M, Thorne J, Weinberg D, Meredith T, Kuppermann B . Course of cytomegalovirus retinitis in the era of highly active antiretroviral therapy: 2. Second eye involvement and retinal detachment. Ophthalmology. 2004; 111(12):2232-9. DOI: 10.1016/j.ophtha.2004.05.028. View

11.

Kempen J, Jabs D, Dunn J, West S, Tonascia J . Retinal detachment risk in cytomegalovirus retinitis related to the acquired immunodeficiency syndrome. Arch Ophthalmol. 2001; 119(1):33-40. View

12.

Canzano J, Morse L, Wendel R . Surgical repair of cytomegalovirus-related retinal detachment without silicone oil in patients with AIDS. Retina. 1999; 19(4):274-80. DOI: 10.1097/00006982-199907000-00001. View

13.

Freeman W, Friedberg D, Berry C, Quiceno J, Behette M, Fullerton S . Risk factors for development of rhegmatogenous retinal detachment in patients with cytomegalovirus retinitis. Am J Ophthalmol. 1993; 116(6):713-20. DOI: 10.1016/s0002-9394(14)73471-3. View

14.

Jabs D, Ahuja A, Van Natta M, Lyon A, Srivastava S, Gangaputra S . Course of cytomegalovirus retinitis in the era of highly active antiretroviral therapy: five-year outcomes. Ophthalmology. 2010; 117(11):2152-61.e1-2. PMC: 2963687. DOI: 10.1016/j.ophtha.2010.03.031. View

15.

Belfort Jr R . The ophthalmologist and the global impact of the AIDS epidemic LV Edward Jackson Memorial Lecture. Am J Ophthalmol. 2000; 129(1):1-8. DOI: 10.1016/s0002-9394(99)00428-6. View

16.

Lean J, Stern W, IRVINE A, Azen S . Classification of proliferative vitreoretinopathy used in the silicone study. The Silicone Study Group. Ophthalmology. 1989; 96(6):765-71. DOI: 10.1016/s0161-6420(89)32821-1. View

17.

Holland G . AIDS and ophthalmology: the first quarter century. Am J Ophthalmol. 2008; 145(3):397-408. DOI: 10.1016/j.ajo.2007.12.001. View

18.

Morrison V, LaBree L, Azen S, Goldberg D, Freeman W . Results of silicone oil removal in patients with cytomegalovirus retinitis related retinal detachments. Am J Ophthalmol. 2005; 140(5):786-793. DOI: 10.1016/j.ajo.2005.04.059. View

19.

Stier P, Glazer L, Garretson B, Deutsch T . Surgical repair of retinal detachment secondary to cytomegalovirus retinitis. Ophthalmic Surg Lasers. 1999; 30(4):289-94. View

20.

Thorne J, Jabs D, Kempen J, Holbrook J, Nichols C, Meinert C . Incidence of and risk factors for visual acuity loss among patients with AIDS and cytomegalovirus retinitis in the era of highly active antiretroviral therapy. Ophthalmology. 2006; 113(8):1432-40. DOI: 10.1016/j.ophtha.2006.03.021. View